Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.9% | +4.6% | 2 / 3 | +26.3% | +4.56 pp | -3.91 pp | +14.5% | 0.74 | 7.99 | 297 | +26,3% | 56,8 | +4,9% | 7.99 | 11.62 | −31,3% |
| Pts | 0 | 0 | 8 | 12 | 12 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 27.000 (close price on 2026-09-30)EPS (TTM): 3.380
Financial charts
1.Revenue & growth
VND bn297Q2/26
1.Revenue & growth
VND bn297Q2/26
2.Profit & growth
VND bn57,2Q2/26
3.Profit mix (Penman)
VND bn68,7Q2/26
4.Margins & cost structure
%11.5%Q2/26
5.Returns & cash cycle
% · days5.0%Q2/26
6.Earnings quality & cash
VND bn50,6Q2/26
7.Asset structure
VND bn995Q2/26
8.Funding & debt health
VND bn · times995Q2/26
9.Revenue backlog
VND bn4,99Q2/26
10.Valuation
times · %7,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.978Q2/26
Adjusted EPS growth, latest quarter
5.6%
Average adjusted EPS growth, 3 quarters
41.4%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26